SEC 13F Intelligence

Altium Capital Management LLC / TVTX

Altium Capital Management LLC’s Travere Therapeutics Inc Position

Does Altium Capital Management LLC own Travere Therapeutics Inc (TVTX)? Not currently — the last reported position was 141.0K shares worth $4M in Q4 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$4M
Q4 2021
Shares
141.0K
% of Portfolio
+1.21%
Quarters Held
5
position exited

Position History TVTX

Reported value by quarter
Q4 ’20: $2MQ4 ’20Q1 ’21: $5MQ1 ’21Q2 ’21: $2MQ2 ’21Q3 ’21: $3MQ3 ’21Q4 ’21: $4MQ4 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2021141.0K$4M+1.21%
Q3 2021141.0K$3M+0.90%
Q2 2021170.5K$2M+0.58%
Q1 2021210.5K$5M+1.46%
Q4 202076.5K$2M+0.78%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Altium Capital Management LLC’s full portfolio or all institutional holders of TVTX.